Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: Is this a distinct entity?

Blood

Volumn 123, Issue 8, 2014, Pages 1199-1206

  Xochelli, Aliki ^a   Kalpadakis, Christina ^b   Gardiner, Anne ^c   Baliakas, Panagiotis ^a,d   Vassilakopoulos, Theodoros P ^e   Mould, Sarah ^c   Davis, Zadie ^c   Stalika, Evangelia ^a   Kanellis, George ^f   Angelopoulou, Maria K ^e   McIver Brown, Neil ^c   Ibbotson, Rachel ^c   Sachanas, Sotirios ^g   Korkolopoulou, Penelope ^e   Athanasiadou, Anastasia ^a   Anagnostopoulos, Achilles ^a   Papadaki, Helen A ^b   Papadaki, Theodora ^f   Stamatopoulos, Kostas ^a,d,h   Pangalis, Gerassimos A ^e,g   Oscier, David ^c   more..

^a G PAPANICOLAOU HOSPITAL   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^d UPPSALA UNIVERSITY   (Sweden)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^f EVANGELISMOS HOSPITAL   (Greece)

^g ATHENS MEDICAL CENTER   (Greece)

^h INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CELL INFILTRATION; CHROMOSOME 7Q; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOGENETICS; IMMUNOPHENOTYPING; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; MIDDLE AGED; MONOCLONAL B CELL LYMPHOCYTOSIS; PRIORITY JOURNAL; SOMATIC HYPERMUTATION; SPLENOMEGALY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; CELL LINEAGE; CHROMOSOME BANDING; CLONE CELLS; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTOSIS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84897861589     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-07-515155     Document Type: Article

References (44)

1. Swerdlow S, Campo E, Harris N, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.
2. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019-5032.
3. Marti GE, Rawstron AC, Ghia P, et al International Familial CLL Consortium. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol. 2005;130(3):325-332. (Pubitemid 43899581)
4. Shanafelt TD, Ghia P, Lanasa MC, Landgren O, Rawstron AC. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia. 2010;24(3):512-520.
5. Ghia P, Prato G, Scielzo C, Stella S, Geuna M, Guida G, Caligaris-Cappio F. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood. 2004;103(6):2337-2342. (Pubitemid 38326255)
6. Ghia P, Caligaris-Cappio F. Monoclonal B-cell lymphocytosis: right track or red herring? Blood. 2012;119(19):4358-4362.
7. Vardi A, Dagklis A, Scarfò L, et al. Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL. Blood. 2013;121(22):4521-4528.
8. Rawstron AC, Bennett FL, O'Connor SJ, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med. 2008;359(6):575-583.
9. Fazi C, Scarfò L, Pecciarini L, et al. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. Blood. 2011;118(25):6618- 6625.
10. Karube K, Scarfò L, Campo E, Ghia P. Monoclonal B cell lymphocytosis and "in situ" lymphoma [published online ahead of print August 30, 2013]. Semin Cancer Biol. 2013.
11. Jares P, Colomer D, Campo E. Molecular pathogenesis of mantle cell lymphoma. J Clin Invest. 2012;122(10):3416-3423.
12. Janz S, Potter M, Rabkin CS. Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer. 2003;36(3):211-223. (Pubitemid 36158194)
13. Pillai RK, Surti U, Swerdlow SH. Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies. Haematologica. 2013;98(10):1571-1580.
14. Amato D, Oscier DG, Davis Z, Mould S, Zheng J, Kolomietz E, Wang C. Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosis. Am J Clin Pathol. 2007;128(2):333-338. (Pubitemid 47262634)
15. Catovsky D, Matutes E. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. Semin Hematol. 1999;36(2):148-154. (Pubitemid 29214068)
16. Zhu D, Oscier DG, Stevenson FK. Splenic lymphoma with villous lymphocytes involves B cells with extensively mutated Ig heavy chain variable region genes. Blood. 1995;85(6):1603-1607.
17. Baliakas P, Kanellis G, Stavroyianni N, Fameli M, Anagnostopoulos A, Stamatopoulos K, Papadaki T. The role of bone marrow biopsy examination at diagnosis of chronic lymphocytic leukemia: a reappraisal. Leuk Lymphoma. 2013;54(11):2377-2384.
18. Hallek M, Cheson BD, Catovsky D, et al International Workshop on Chronic Lymphocytic Leukemia. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111(12):5446-5456.
19. Ibbotson R, Athanasiadou A, Sutton LA, et al. Coexistence of trisomies of chromosomes 12 and 19 in chronic lymphocytic leukemia occurs exclusively in the rare IgG-positive variant. Leukemia. 2012;26(1):170-172.
20. Shaffer LS, Campbel L. ISCN: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger Publishers, Inc; 2009
21. Murray F, Darzentas N, Hadzidimitriou A, et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood. 2008;111(3):1524-1533. (Pubitemid 351213442)
22. Agathangelidis A, Darzentas N, Hadzidimitriou A, et al. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood. 2012;119(19):4467-4475.
23. Lefranc MP, Giudicelli V, Ginestoux C, et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 2009;37(Database issue):D1006-D1012.
24. Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 2008;36 (Web Server issue):W503-W508.
25. Kanellis G, Stephanoudaki E, Kokkini G, Papadaki E, Papadaki T. Marginal Zone Lymphomas (MZL) Presenting with Absolute Monoclonal Lymphocytosis and/or Monoclonal Gammopathy: A Report of 8 Cases. Bordeaux, FranceL EHAP; 2008.
26. Siakantaris MP, Pangalis GA, Dimitriadou E, et al. Early-stage gastric MALT lymphoma: is it a truly localized disease? Oncologist. 2009;14(2):148-154.
27. Majid A, Lin TT, Best G, et al. CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL. Leuk Res. 2011;35(6):750-756.
28. Gattei V, Bulian P, Del Principe MI, et al. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. Blood. 2008;111(2):865-873.
29. Buggins AG, Levi A, Gohil S, et al. Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9. Br J Haematol. 2011;154(2):216-222.
30. Angelopoulou MK, Kontopidou FN, Pangalis GA. Adhesion molecules in B-chronic lymphoproliferative disorders. Semin Hematol. 1999;36(2):178-197. (Pubitemid 29214072)
31. Zucchetto A, Benedetti D, Tripodo C, et al. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Cancer Res. 2009;69(9):4001-4009.
32. Zucchetto A, Vaisitti T, Benedetti D, et al. The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells. Leukemia. 2012;26(6):1301-1312.
33. Ponzoni M, Kanellis G, Pouliou E, et al. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology? Am J Surg Pathol. 2012;36(11):1609-1618.
34. Salido M, Baró C, Oscier D, et al. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group. Blood. 2010;116(9):1479-1488.
35. Traverse-Glehen A, Baseggio L, Bauchu EC, et al. Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity? Blood. 2008;111(4):2253-2260. (Pubitemid 351454029)
36. Varettoni M, Arcaini L, Zibellini S, et al. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms. Blood. 2013;121(13):2522-2528.
37. Kalpadakis C. Marginal zone lymphomas. A clinical, laboratory and molecular study of 178 patients [PhD thesis]. Available at: http://phdtheses. ekt.gr/eadd/handle/10442/23631. Accessed 2008.
38. Kalpadakis C, Pangalis GA, Sachanas S, et al. Primary bone marrow marginal zone lymphoma (PBMMZL).A new disease entity? [Abstract] Haematologica. 2010;95(S2).
39. Corcoran MM, Mould SJ, Orchard JA, et al. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations. Oncogene. 1999;18(46):6271-6277.
40. Parker E, Macdonald JR, Wang C. Molecular characterization of a t(2;7) translocation linking CDK6 to the IGK locus in CD5(-) monoclonal B-cell lymphocytosis. Cancer Genet. 2011;204(5):260-264.
41. Best OG, Gardiner AC, Davis ZA, et al. A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease. Leukemia. 2009;23(1):212-214.
42. Bikos V, Darzentas N, Hadzidimitriou A, et al. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications. Leukemia. 2012;26(7):1638-1646.
43. Rawstron AC. Monoclonal B cell lymphocytosis - what does it really mean? Curr Hematol Malig Rep. 2013;8(1):52-59.
44. Rossi D, Sozzi E, Puma A, et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol. 2009;146(1):64-75.